1. Home
  2. CODX vs ASPS Comparison

CODX vs ASPS Comparison

Compare CODX & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • ASPS
  • Stock Information
  • Founded
  • CODX 2013
  • ASPS 1999
  • Country
  • CODX United States
  • ASPS Luxembourg
  • Employees
  • CODX N/A
  • ASPS N/A
  • Industry
  • CODX Medical/Dental Instruments
  • ASPS Other Consumer Services
  • Sector
  • CODX Health Care
  • ASPS Consumer Discretionary
  • Exchange
  • CODX Nasdaq
  • ASPS Nasdaq
  • Market Cap
  • CODX 9.8M
  • ASPS 9.2M
  • IPO Year
  • CODX 2017
  • ASPS N/A
  • Fundamental
  • Price
  • CODX $0.28
  • ASPS $8.58
  • Analyst Decision
  • CODX Buy
  • ASPS
  • Analyst Count
  • CODX 2
  • ASPS 0
  • Target Price
  • CODX $5.50
  • ASPS N/A
  • AVG Volume (30 Days)
  • CODX 462.7K
  • ASPS 66.7K
  • Earning Date
  • CODX 08-07-2025
  • ASPS 07-24-2025
  • Dividend Yield
  • CODX N/A
  • ASPS N/A
  • EPS Growth
  • CODX N/A
  • ASPS N/A
  • EPS
  • CODX N/A
  • ASPS N/A
  • Revenue
  • CODX $3,497,583.00
  • ASPS $164,104,000.00
  • Revenue This Year
  • CODX N/A
  • ASPS $38.29
  • Revenue Next Year
  • CODX $42.11
  • ASPS N/A
  • P/E Ratio
  • CODX N/A
  • ASPS N/A
  • Revenue Growth
  • CODX N/A
  • ASPS 13.12
  • 52 Week Low
  • CODX $0.23
  • ASPS $3.46
  • 52 Week High
  • CODX $2.23
  • ASPS $13.12
  • Technical
  • Relative Strength Index (RSI)
  • CODX 43.19
  • ASPS 57.42
  • Support Level
  • CODX $0.26
  • ASPS $9.80
  • Resistance Level
  • CODX $0.29
  • ASPS $11.07
  • Average True Range (ATR)
  • CODX 0.02
  • ASPS 0.99
  • MACD
  • CODX 0.00
  • ASPS 0.14
  • Stochastic Oscillator
  • CODX 26.83
  • ASPS 61.38

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

Share on Social Networks: